Amylin-pathway peptide
Cagrilintide
An amylin-analog peptide sometimes discussed alongside GLP-1 therapies for appetite regulation, generally offered off-label or in combination programs.
Overview
Cagrilintide targets a different appetite-regulating pathway than GLP-1 medications and is often discussed as a complementary option. Availability and prescribing approach vary significantly by clinic, so eligibility screening matters.
